Teva Pharmaceutical Industries Ltd. Logo

Teva Pharmaceutical Industries Ltd.

A biopharmaceutical firm that develops and markets generic and specialty medicines.

TEVA | TA

Overview

Corporate Details

ISIN(s):
US8816242098 (+1 more)
LEI:
549300BAFGM4RC74ZJ94
Country:
Israel
Address:
124 DVORA HANEVIA, 6944020 TEL AVIV

Description

Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical company that develops, produces, and markets a broad portfolio of medicines. The company's business is centered on two main segments: generic medicines and innovative specialty treatments. As one of the world's largest manufacturers of generic drugs, Teva provides a wide range of affordable products across numerous therapeutic areas. Its specialty and biopharmaceutical research focuses on developing novel treatments, with a significant emphasis on central nervous system (CNS) disorders, including therapies for schizophrenia, tardive dyskinesia, and bipolar disorder. The company's portfolio also includes complex generics, biosimilars, and active pharmaceutical ingredients (APIs), while leveraging advanced technologies to enhance drug development and manufacturing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 00:34
Immediate Report
English 45.7 KB
2025-12-19 00:34
Immediate Report
English 36.3 KB
2025-12-19 00:32
Immediate Report
English 46.4 KB
2025-12-19 00:32
Immediate Report
English 36.3 KB
2025-12-12 00:39
Immediate Report
English 106.5 KB
2025-12-12 00:39
Immediate Report
English 36.4 KB
2025-12-12 00:28
Immediate Report
English 47.7 KB
2025-12-12 00:28
Immediate Report
English 36.4 KB
2025-12-12 00:28
Immediate Report
English 47.2 KB
2025-12-12 00:28
Immediate Report
English 36.3 KB
2025-12-05 00:10
Immediate Report
English 46.4 KB
2025-12-05 00:10
Immediate Report
English 36.4 KB
2025-12-04 22:01
4
English 7.4 KB
2025-12-02 00:11
Immediate Report
English 46.4 KB
2025-12-02 00:11
Immediate Report
English 36.3 KB

Automate Your Workflow. Get a real-time feed of all Teva Pharmaceutical Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Teva Pharmaceutical Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Teva Pharmaceutical Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.